LACK OF ASSOCIATION BETWEEN CYTOMEGALOVIRUS-INFECTION, HLA MATCHING AND THE VANISHING BILE-DUCT SYNDROME AFTER LIVER-TRANSPLANTATION

被引:42
作者
PAYA, CV
WIESNER, RH
HERMANS, PE
LARSONKELLER, JJ
ILSTRUP, DM
KROM, RAF
MOORE, SB
LUDWIG, J
SMITH, TF
机构
[1] MAYO CLIN & MAYO FDN,DIV INFECT DIS & INTERNAL MED,ROCHESTER,MN 55905
[2] MAYO CLIN & MAYO FDN,DIV GASTROENTEROL & INTERNAL MED,ROCHESTER,MN 55905
[3] MAYO CLIN & MAYO FDN,BIOSTAT SECT,ROCHESTER,MN 55905
[4] MAYO CLIN & MAYO FDN,DEPT LAB MED & PATHOL,ROCHESTER,MN 55905
[5] MAYO CLIN & MAYO FDN,TRANSPLANTAT SURG SECT,ROCHESTER,MN 55905
关键词
D O I
10.1002/hep.1840160113
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In this study we evaluated the association between cytomegalovirus infection alone or in relation to human leukocyte antigen matching and the development of vanishing bile duct syndrome, a form of chronic hepatic allograft rejection. A total of 81 consecutive liver transplant recipients were studied. Cytomegalovirus infection developed in 46 recipients (57%), and vanishing bile duct syndrome occurred in 9 recipients (11%). Cytomegalovirus infection developed in only five of the nine patients with vanishing bile duct syndrome. Univariate analysis of pretransplant recipient/donor cytomegalovirus serological tests and human leukocyte antigen typing showed they were not significant risk factors for the development of vanishing bile duct syndrome. Time-dependent analysis of cytomegalovirus infection after transplantation as a risk factor for vanishing bile duct syndrome, in a multivariate analysis with human leukocyte antigen match, showed no statistical significance. In our study, no association was found between cytomegalovirus infection alone or in relation to class I or II human leukocyte antigen match and the subsequent development of vanishing bile duct syndrome.
引用
收藏
页码:66 / 70
页数:5
相关论文
共 35 条
[1]   A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF ORAL ACYCLOVIR FOR THE PREVENTION OF CYTOMEGALO-VIRUS DISEASE IN RECIPIENTS OF RENAL-ALLOGRAFTS [J].
BALFOUR, HH ;
CHACE, BA ;
STAPLETON, JT ;
SIMMONS, RL ;
FRYD, DS .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (21) :1381-1387
[2]  
BAUR MP, 1984, HISTOCOMPATIBILITY T, P333
[3]   A COMPLEX BETWEEN THE MHC CLASS-I HOMOLOG ENCODED BY HUMAN CYTOMEGALOVIRUS AND BETA-2 MICROGLOBULIN [J].
BROWNE, H ;
SMITH, G ;
BECK, S ;
MINSON, T .
NATURE, 1990, 347 (6295) :770-772
[4]   PRIMARY CYTOMEGALOVIRUS AND OPPORTUNISTIC INFECTIONS - INCIDENCE IN RENAL-TRANSPLANT RECIPIENTS [J].
CHATTERJEE, SN ;
FIALA, M ;
WEINER, J ;
STEWART, JA ;
STACEY, B ;
WARNER, N .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1978, 240 (22) :2446-2449
[5]  
COLONNA JO, 1988, ARCH SURG-CHICAGO, V123, P360
[6]  
COX DR, 1972, J R STAT SOC B, V34, P187
[7]  
DONALDSON PT, 1987, LANCET, V1, P945
[8]   EARLY INFECTIONS IN KIDNEY, HEART, AND LIVER-TRANSPLANT RECIPIENTS ON CYCLOSPORINE [J].
DUMMER, JS ;
HARDY, A ;
POORSATTAR, A ;
HO, M .
TRANSPLANTATION, 1983, 36 (03) :259-267
[9]   CYTOMEGALO-VIRUS INFECTION IS ASSOCIATED WITH CARDIAC ALLOGRAFT-REJECTION AND ATHEROSCLEROSIS [J].
GRATTAN, MT ;
MORENOCABRAL, CE ;
STARNES, VA ;
OYER, PE ;
STINSON, EB ;
SHUMWAY, NE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (24) :3561-3566
[10]   THE EFFECT OF CYTOMEGALOVIRUS-INFECTION ON THE HOST RESPONSE TO FOREIGN AND HAPTEN-MODIFIED SELF HISTOCOMPATIBILITY ANTIGENS [J].
GRUNDY, JE ;
SHEARER, GM .
TRANSPLANTATION, 1984, 37 (05) :484-490